TGF-β and FRF-21: association with coronary artery disease in patients with type 2 diabetes and obesity

TGF-β and FRF-21: association with coronary artery disease in patients with type 2 diabetes and obesity

Backgraund: Obesity and type 2 diabetes mellitus (T2DM) are associated with with an increased risk of cardiovascular disease (CVD) and coronary artery disease (CAD), in particular. Obesity lead to several fibrotic processes, including activation of transforming growth factor β (TGF-&bet...

Full description

Bibliographic Details
Main Authors:	Teona A. Shvangiradze, Irina Z. Bondarenko, Ekaterina A. Troshina, Larisa V. Nikankina, Svetlana S. Kukharenko, Marina V. Shestakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2017-11-01
Series:	Ожирение и метаболизм
Subjects:	obesity diabetes mellitus cardiovascular disease transforming growth factor β fibroblast growth factor
Online Access:	https://www.omet-endojournals.ru/jour/article/view/9358

Similar Items

Angiotensin II and transforming growth factor β affect cardiovascular and renal disease in patients with type 2 diabetes mellitus: benefits of dpp-4 inhibitors treatment
by: Teona A. Shvangiradze, et al.
Published: (2019-12-01)

Molecular description of fibroblast growth factor and mechanisms by which fibroblast growth factor-21 mediating biological actions and acting as a biologic biomarker of cardiovascular diseases
by: Leta Shiferaw Melaku, et al.
Published: (2020-01-01)

Serum FGF21 Levels in Obese Korean Children and Adolescents
by: Joonwoo Baek, et al.
Published: (2017-09-01)

Role of Rhodomyrtus tomentosa (Aiton) Hassk. in regulating the expression of fibroblast growth factor family in the liver of rat in a breast cancer model
by: Putri Cahaya Situmorang, et al.
Published: (2024-07-01)

Fibroblast Growth Factor 2—A Review of Stabilisation Approaches for Clinical Applications
by: Leah Benington, et al.
Published: (2020-06-01)

Growth factors of fibroblasts and vascular en-dothelium in the early stages of knee osteoarthritis
by: Puchinyan D.M., et al.
Published: (2018-09-01)

Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
by: Kelvin H. M. Kwok, et al.
Published: (2017-05-01)

Deficiency of fibroblast growth factor 21 aggravates obesity-induced atrophic responses in skeletal muscle
by: Chu-Sook Kim, et al.
Published: (2019-07-01)

Effect of 12 weeks of light and heavy interval training on the level of irisin and fibroblast growth factor 21 in obese and overweight women: A clinical trial study
by: Mohammad Reza Hamedinia, et al.
Published: (2019-03-01)

Sepsis and Fibroblast Growth Factor 21: A New Acute Phase Reactant?
by: Selcen Deveci, et al.
Published: (2022-09-01)

Role of FGF21 and Leptin for the Diagnosis of Metabolic Health in Children with and without Obesity
by: Eleni M. Domouzoglou, et al.
Published: (2023-12-01)

Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use
by: Akshan Puar, MBBS, et al.
Published: (2022-09-01)

Microvascularization and Expression of Fibroblast Growth Factor and Vascular Endothelial Growth Factor and Their Receptors in the Mare Oviduct
by: Pedro Pinto-Bravo, et al.
Published: (2021-04-01)

Concentrations of serum VEGF and bFGF in Mongolia patients with diabetic retinopathy
by: Jun Zhang, et al.
Published: (2016-07-01)

The starvation hormone, fibroblast growth factor-21, extends lifespan in mice
by: Yuan Zhang, et al.
Published: (2012-10-01)

Exploring the correlation between serum fibroblast growth factor-21 levels and Sarcopenia: a systematic review and meta-analysis
by: Hao Liu, et al.
Published: (2023-06-01)

Effect of two different volumes of resistance training on serum level of fibroblast growth factor-21, body fat percentage and mobility in obese elderly women
by: Zeinab Fattahi, et al.
Published: (2020-12-01)

Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia
by: Gholamhosein Yaghoobi, et al.
Published: (2020-02-01)

Characterization of the biological properties of FGF-9
by: Seet, L, et al.
Published: (1996)

The effect of Tualang honey on viability of human skin fibroblast /
by: Nornadia Salehuddin, 1992- 637465, et al.
Published: (2015)

The effect of Tualang honey on viability of human skin fibroblast [electronic resource] /
by: Nornadia Salehuddin, 1992- 637465
Published: (2015)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
by: Navid Sobhani, et al.
Published: (2018-07-01)

Epidermal and fibroblast growth factor incorporated polyvinyl alcohol electrospun nanofibers as burn wound dressing scaffold.
by: Ismail A. Asiri, Amanah
Published: (2023)

The potential impact of the hypovitaminosis D on metabolic complications in obese adolescents – Preliminary results
by: Malgorzata Wojcik, et al.
Published: (2017-12-01)

Value of vascular growth factors after stenting coronary arteries in patients with IHD
by: Dana Taizhanova, et al.
Published: (2019-06-01)

Hormonal regulation of menstrual function in patients of reproductive age with acromegaly
by: Svetlana Yu. Vorotnikova, et al.
Published: (2018-12-01)

Transcriptional Regulation of Fibroblast Growth Factor 21 Expression
by: Kwi-Hyun Bae, et al.
Published: (2014-06-01)

Fibroblast Growth Factor 2 Protein Stability Provides Decreased Dependence on Heparin for Induction of FGFR Signaling and Alters ERK Signaling Dynamics
by: Zuzana Koledova, et al.
Published: (2019-12-01)

Fibroblast growth factors as tissue repair and regeneration therapeutics
by: Quentin M. Nunes, et al.
Published: (2016-01-01)

Distinct effects of Fgf7 and Fgf10 on the terminal differentiation of murine bladder urothelium revealed using an organoid culture system
by: Kazuto Suda, et al.
Published: (2023-10-01)

Fibroblast Growth Factors in Depression
by: Zheng Deng, et al.
Published: (2019-02-01)

Skeletal FGFR1 signaling is necessary for regulation of serum phosphate level by FGF23 and normal life span
by: Yuichi Takashi, et al.
Published: (2021-09-01)

Mutations in fibroblast growth factor (FGF8) and FGF10 identified in patients with conotruncal defects
by: Kun Sun, et al.
Published: (2020-07-01)

Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals
by: Lynae J. Hanks, et al.
Published: (2015-06-01)

Computer-aided engineering of stabilized fibroblast growth factor 21
by: Gabin de La Bourdonnaye, et al.
Published: (2024-12-01)

Chronic Kidney Disease Is Associated with Increased Plasma Levels of Fibroblast Growth Factors 19 and 21
by: Małgorzata Marchelek-Myśliwiec, et al.
Published: (2019-10-01)

Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction
by: Yixuan Ma, et al.
Published: (2021-11-01)

A Case of Pulmonary Tumor Thrombotic Microangiopathy Suggested by the Presence of Tumor Cells in Peripheral Blood
by: Yusuke Kawanaka, et al.
Published: (2020-07-01)

FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
by: Kook Hwan Kim, et al.
Published: (2014-08-01)

Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT
by: Sundong Lin, et al.
Published: (2020-02-01)